Skip to main content

Colgate-Palmolive Co

corporate_fare Company Profile

Colgate-Palmolive Co

CL·NYSE·Industrial Applications And Services·CIK 0000021665

Colgate-Palmolive Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The company markets its products in over 200 countries and territories globally. Founded in 1806 and incorporated in Delaware in 1923, Colgate-Palmolive is a leader in Oral Care, holding global leadership in the toothpaste and manual toothbrush categories based on market share data. Its toothpaste brands include Colgate, Darlie, elmex, hello, meridol, Sorriso, and Tom's of Maine. Toothbrushes are sold under brands such as Colgate, Darlie, elmex, and meridol, while mouthwashes include Colgate, elmex, and meridol. The Oral Care business also provides pharmaceutical products for dentists and other oral health professionals. The company focuses on leveraging its global brand reach, science-based innovation, omni-channel demand generation, and capabilities in data, analytics, and artificial intelligence.

Colgate-Palmolive Co (NYSE:CL) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 13 items for CL at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-10-30, rated 7/10. Across its 13 most recent items scored 7 or higher, the top rating is 8/10, with 7 rated 8 or above. Recent SEC coverage for CL spans 8-K, 10-Q, 10-K.

Recent high-impact activity:

  • Colgate Q3 Beats: EPS $0.94, Gross Margin Up 80 bps, Full-Year EPS Guidance Raised to 5-7%
  • Colgate-Palmolive Posts 3Q EPS of 94 Cents
  • Colgate Warns New Tariffs Will Outweigh Q2 Refund Windfall, Shares Slide
  • Colgate-Palmolive Q2 2026: EPS Beat, Restructuring Expansion, and $5B Buyback Program
  • Colgate-Palmolive Lifts FY26 EPS View, But Stock Drops 2.8% on Weak Q2 Profit

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$20.38B
Net Income
$2.13B
Diluted EPS
$2.63
Op. Cash Flow
$4.2B
Free Cash Flow
$3.63B
Gross Profit
$12.25B
Operating Income
$3.31B
Cash & Equivalents
$1.29B
Total Debt
$7.99B
Debt / Equity
147.89×
Net Margin
10.5%
Shares Outstanding
801.24M sh
Source: 10-K · filed 2026-02-23 · accession 0000021665-26-000006

Short Interest & Short Volume

3.75 days to cover

FINRA reported short interest of 18,543,803 shares in CL as of the October 30, 2026 settlement, a 6.5% increase from the prior period — about 3.8 days to cover at its recent average daily volume. On November 20, 2026, 38.1% of CL volume reported to FINRA trade-reporting facilities was marked short.

Short interest (bi-monthly positions)18,543,803 shares as of October 30, 2026
Change vs prior period▲ 6.5%
Days to cover3.75 at avg daily volume of 4,946,999
Daily short volume (FINRA facilities)38.1% of 2,349,756 shares on November 20, 2026
5-day average short volume43.8%

Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.

Browse all tickers starting with C →
$98.65 -0.08% today
52-week range · as of 2026-10-30 $74.55 – $99.33
Market cap
$78.48B
Volume
6.6M (1.2× avg)
3-mo avg 5.3M
Live data · 2026-11-21 06:28 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed CL - Latest Insights

CL
Oct 30, 2026, 7:56 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $96.14
Real-time Price: $98.65 info
Change: +$2.51 (+3%) info
Market Cap: $78.482B info
CL
Oct 30, 2026, 6:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $94.00
Real-time Price: $98.65 info
Change: +$4.65 (+5%) info
Market Cap: $78.482B info
CL
Jul 31, 2026, 10:13 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $91.04
Real-time Price: $98.65 info
Change: +$7.62 (+8%) info
Market Cap: $78.482B info
CL
Jul 31, 2026, 8:32 AM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $89.95
Real-time Price: $98.65 info
Change: +$8.70 (+10%) info
Market Cap: $78.482B info
CL
Jul 31, 2026, 8:21 AM EDT
Source: dpa-AFX
Importance Score:
8
Price at Filing: $90.00
Real-time Price: $98.65 info
Change: +$8.65 (+10%) info
Market Cap: $78.482B info
CL
Jul 31, 2026, 7:58 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $90.00
Real-time Price: $98.65 info
Change: +$8.65 (+10%) info
Market Cap: $78.482B info
CL
Jul 31, 2026, 7:12 AM EDT
Source: Dow Jones Newswires
Importance Score:
8
Price at Filing: $89.30
Real-time Price: $98.65 info
Change: +$9.35 (+10%) info
Market Cap: $78.482B info
CL
Jul 29, 2026, 2:35 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $94.49
Real-time Price: $98.65 info
Change: +$4.16 (+4%) info
Market Cap: $78.482B info
CL
May 01, 2026, 4:06 PM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $87.00
Real-time Price: $98.65 info
Change: +$11.65 (+13%) info
Market Cap: $78.482B info
CL
May 01, 2026, 6:55 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $86.00
Real-time Price: $98.65 info
Change: +$12.65 (+15%) info
Market Cap: $78.482B info
CL
Mar 12, 2026, 4:33 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $87.80
Real-time Price: $98.65 info
Change: +$10.85 (+12%) info
Market Cap: $78.482B info
CL
Feb 23, 2026, 4:03 PM EST
Filing Type: 10-K
Importance Score:
8
Price at Filing: $97.10
Real-time Price: $98.65 info
Change: +$1.55 (+2%) info
Market Cap: $78.482B info
CL
Jan 30, 2026, 7:57 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $86.85
Real-time Price: $98.65 info
Change: +$11.80 (+14%) info
Market Cap: $78.482B info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets